0.012616 0.000000 0.000000 0.000000 0.012616 0.000000 0.000000 0.000000 0.012616 0.00000 0.00000 0.00000 Yadav, M.K. Redman, J.E. Alvarez-Gutierrez, J.M. Zhang, Y. Stout, C.D. Ghadiri, M.R. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 48 90.00 90.00 90.00 79.265 79.265 79.265 C2 H4 O 44.053 ACETYL GROUP non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 44 9723 10.1021/BI050742A 16008357 Structure-Based Engineering of Internal Cavities in Coiled-Coil Peptides 2005 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 114.0 1 2002-10-15 SINGLE WAVELENGTH M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE RIGAKU RU200 DIMER ASYMMETRIC UNIT OF FOUR HELIX BUNDLE MUTATION LEU26ALA 4030.757 GENERAL CONTROL PROTEIN GCN4 YES 2 syn polymer GCN4 LEUCINE ZIPPER, AMINO ACID BIOSYNTHESIS REGULATORY PROTEIN, PLI no yes (ACE)RMKQIEDKLEEILSKLYHIENELARAKKLLGER XRMKQIEDKLEEILSKLYHIENELARAKKLLGER A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n 1 2.5 50 7.00 2.5 M NACL, 100 MM NAAC, 200 MM LI2SO4, PH 4.5 repository Initial release Version format compliance Version format compliance 1 0 2004-10-13 1 1 2011-05-08 1 2 2011-07-13 GCN4 LEUCINE ZIPPER CORE MUTANT P-LI GCN4 LEUCINE ZIPPER CORE MUTANT P-LI STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES HELIX CAPPING IN THE GCN4 LEUCINE ZIPPER GCN4 LEUCINE ZIPPER COMPLEXED WITH SPECIFIC ATF/CREB SITE DEOXYRIBONUCLEIC ACID ATOMIC STRUCTURE OF THE ECTODOMAIN FROM HIV -1 GP41 THE STRUCTURE OF AN HIV-1 SPECIFIC CELL ENTRY INHIBITOR INCOMPLEX WITH THE HIV-1 GP41 TRIMERIC CORE HUMAN VIMENTIN COIL 2B FRAGMENT LINKED TO GCN4 LEUCINE ZIPPER (Z2B) CRYSTAL STRUCTURE OF C14LINKMID/IQN17: A CROSS-LINKED INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 HYDROPHOBIC POCKET GLYTM1BZIP: A CHIMERIC PEPTIDE MODEL OF THE N-TERMINUS OF ARAT SHORT ALPHA TROPOMYOSIN WITH THE N-TERMINUS ENCODED BYEXON 1B COILED COIL TRIMER GCN4-PVLS SER AT BURIED D POSITION GCN4-PVLT COILED-COIL TRIMER WITH THREONINE AT THE D(12)POSITION GCN4-PVTL COILED-COIL TRIMER WITH THREONINE AT THE A(16)POSITION GCN4-PVSL COILED-COIL TRIMER WITH SERINE AT THE A(16)POSITION CRYSTAL STRUCTURE OF THE C-TERMINAL REGION OF STRIATEDMUSCLE ALPHA-TROPOMYOSIN AT 2.7 ANGSTROM RESOLUTION PLACEMENT OF THE STRUCTURAL PROTEINS IN SINDBIS VIRUS CRYSTAL STRUCTURE OF A ZIF23-GCN4 CHIMERA BOUND TO DNA VISUALIZING AN UNSTABLE COILED COIL: THE CRYSTAL STRUCTUREOF AN N-TERMINAL SEGMENT OF THE SCALLOP MYOSIN ROD CRYSTAL STRUCTURE OF GCN4-PIQ, A TRIMERIC COILED COIL WITH BURIED POLAR RESIDUES GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A TRIGONAL AUTOMATICSOLUTION ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL AUTOMATIC SOLUTION ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TRIGONAL FORM ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL FORM GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A COMPLEXED WITH BENZENE TMZIP: A CHIMERIC PEPTIDE MODEL OF THE N- TERMINUS OF ALPHA TROPOMYOSIN, NMR, 15 STRUCTURES AN ANTI-PARALLEL FOUR HELIX BUNDLE ( ACETIMIDE MODIFICATION). AN ANTI-PARALLEL FOUR HELIX BUNDLE. ABA DOES NOT AFFECT TOPOLOGY OF PLI. AN ANTI-PARALLEL FOUR HELIX BUNDLE AN ANTI-PARALLEL FOUR HELIX BUNDLE AN ANTI-PARALLEL TO PARALLEL SWITCH. GCN4 (BASIC REGION, LEUCINE ZIPPER) COMPLEX WITH AP-1 DEOXYRIBONUCLEIC ACID GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE DIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE TRIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16LYS IN THE DIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE DIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE TRIMERIC STATE LEUCINE ZIPPER MONOMER (NMR, 20 STRUCTURES) GCN4 BASIC DOMAIN, LEUCINE ZIPPER COMPLEXED WITH ATF/CREB SITE DEOXYRIBONUCLEIC ACID GCN4 LEUCINE ZIPPER PDBE Y PDBE 2003-09-15 REL BASED ON SEQUENCE FROM SACCHAROMYCES CEREVISIAE (BAKER'S YEAST) 4932 BAKER'S YEAST SACCHAROMYCES CEREVISIAE sample ENGINEERED RESIDUE LEU 274 ALA, CHAINS A AND B n 1 -1 A ARG 1 n 2 ARG 1 A MET 2 n 3 MET 2 A LYS 3 n 4 LYS 3 A GLN 4 n 5 GLN 4 A ILE 5 n 6 ILE 5 A GLU 6 n 7 GLU 6 A ASP 7 n 8 ASP 7 A LYS 8 n 9 LYS 8 A LEU 9 n 10 LEU 9 A GLU 10 n 11 GLU 10 A GLU 11 n 12 GLU 11 A ILE 12 n 13 ILE 12 A LEU 13 n 14 LEU 13 A SER 14 n 15 SER 14 A LYS 15 n 16 LYS 15 A LEU 16 n 17 LEU 16 A TYR 17 n 18 TYR 17 A HIS 18 n 19 HIS 18 A ILE 19 n 20 ILE 19 A GLU 20 n 21 GLU 20 A ASN 21 n 22 ASN 21 A GLU 22 n 23 GLU 22 A LEU 23 n 24 LEU 23 A ALA 24 n 25 ALA 24 A ARG 25 n 26 ARG 25 A ALA 26 n 27 ALA 26 A LYS 27 n 28 LYS 27 A LYS 28 n 29 LYS 28 A LEU 29 n 30 LEU 29 A LEU 30 n 31 LEU 30 A GLY 31 n 32 GLY 31 A GLU 32 n 33 GLU 32 A n 34 33 A n 1 -1 B ARG 1 n 2 ARG 1 B MET 2 n 3 MET 2 B LYS 3 n 4 LYS 3 B GLN 4 n 5 GLN 4 B ILE 5 n 6 ILE 5 B GLU 6 n 7 GLU 6 B ASP 7 n 8 ASP 7 B LYS 8 n 9 LYS 8 B LEU 9 n 10 LEU 9 B GLU 10 n 11 GLU 10 B GLU 11 n 12 GLU 11 B ILE 12 n 13 ILE 12 B LEU 13 n 14 LEU 13 B SER 14 n 15 SER 14 B LYS 15 n 16 LYS 15 B LEU 16 n 17 LEU 16 B TYR 17 n 18 TYR 17 B HIS 18 n 19 HIS 18 B ILE 19 n 20 ILE 19 B GLU 20 n 21 GLU 20 B ASN 21 n 22 ASN 21 B GLU 22 n 23 GLU 22 B LEU 23 n 24 LEU 23 B ALA 24 n 25 ALA 24 B ARG 25 n 26 ARG 25 B ALA 26 n 27 ALA 26 B LYS 27 n 28 LYS 27 B LYS 28 n 29 LYS 28 B LEU 29 n 30 LEU 29 B LEU 30 n 31 LEU 30 B GLY 31 n 32 GLY 31 B GLU 32 n 33 GLU 32 B n 34 33 B author_and_software_defined_assembly PQS 4 tetrameric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 -1.0000000000 0.0000000000 19_655 -x+7/4,-z+3/4,-y+3/4 crystal symmetry operation 138.7137500000 59.4487500000 59.4487500000 1 A CA GLU 32 A CA GLU 33 1 Y 1 A C GLU 32 A C GLU 33 1 Y 1 A O GLU 32 A O GLU 33 1 Y 1 A CB GLU 32 A CB GLU 33 1 Y 1 A CG GLU 32 A CG GLU 33 1 Y 1 A CD GLU 32 A CD GLU 33 1 Y 1 A OE1 GLU 32 A OE1 GLU 33 1 Y 1 A OE2 GLU 32 A OE2 GLU 33 1 Y 1 B CA GLU 32 B CA GLU 33 1 Y 1 B C GLU 32 B C GLU 33 1 Y 1 B O GLU 32 B O GLU 33 1 Y 1 B CB GLU 32 B CB GLU 33 1 Y 1 B CG GLU 32 B CG GLU 33 1 Y 1 B CD GLU 32 B CD GLU 33 1 Y 1 B OE1 GLU 32 B OE1 GLU 33 1 Y 1 B OE2 GLU 32 B OE2 GLU 33 1 Y 1 A ACE -1 A ACE 1 1 Y 1 A ARG 33 A ARG 34 1 Y 1 B ACE -1 B ACE 1 1 Y 1 B ARG 33 B ARG 34 1 Y 1 11.02 1.70 111.00 122.02 A A A CB CG CD1 LEU LEU LEU 13 13 13 N 1 -12.52 1.60 122.70 110.18 A A A O C N GLY GLY GLU 31 31 32 Y 1 6.47 0.50 120.30 126.77 B B B NE CZ NH1 ARG ARG ARG 1 1 1 N 1 -9.98 1.20 123.30 113.32 B B B OE1 CD OE2 GLU GLU GLU 22 22 22 N 1 11.18 1.70 111.00 122.18 B B B CB CG CD2 LEU LEU LEU 29 29 29 N 1 A A CA CB SER SER 14 14 0.094 0.015 1.525 1.619 N 1 A A CB OG SER SER 14 14 -0.083 0.013 1.418 1.335 N 1 A A N CA LYS LYS 15 15 -0.151 0.020 1.459 1.308 N 1 A A CD1 CE1 TYR TYR 17 17 -0.101 0.015 1.389 1.288 N 1 A A CE1 CZ TYR TYR 17 17 -0.128 0.013 1.381 1.253 N 1 A A CD OE2 GLU GLU 20 20 0.085 0.011 1.252 1.337 N 1 A A CD OE1 GLU GLU 22 22 0.172 0.011 1.252 1.424 N 1 A A CD OE2 GLU GLU 22 22 0.107 0.011 1.252 1.359 N 1 A A CE NZ LYS LYS 28 28 0.191 0.025 1.486 1.677 N 1 B B NE CZ ARG ARG 1 1 0.091 0.013 1.326 1.417 N 1 B B CG CD GLU GLU 6 6 0.128 0.015 1.515 1.643 N 1 B B CD OE1 GLU GLU 6 6 0.132 0.011 1.252 1.384 N 1 B B CD OE2 GLU GLU 6 6 0.095 0.011 1.252 1.347 N 1 B B CD CE LYS LYS 8 8 0.208 0.025 1.508 1.716 N 1 B B CE NZ LYS LYS 8 8 0.174 0.025 1.486 1.660 N 1 B B CD OE1 GLU GLU 11 11 0.090 0.011 1.252 1.342 N 1 B B CB CG2 ILE ILE 12 12 -0.226 0.031 1.524 1.298 N 1 B B CD OE1 GLU GLU 20 20 0.079 0.011 1.252 1.331 N 1 B B CD OE2 GLU GLU 20 20 -0.082 0.011 1.252 1.170 N 1 B B CG CD LYS LYS 28 28 0.251 0.034 1.520 1.771 N 39.946 0.29885 0.22603 0.22883 2.40 55.90 158 3488 4.3 99.83 7.078 0.167 RANDOM 1 THROUGHOUT MOLECULAR REPLACEMENT 0.335 0.281 2.40 55.90 0 520 0 0 520 2.214 35.448 1UO0 3657 2.000 0.12300 1 5.8000 12.300 100.0 refinement REFMAC data reduction CrystalClear (MSC/RIGAKU) data scaling SCALA phasing MOLREP GENERAL CONTROL PROTEIN GCN4 Structure Based Engineering of Internal Molecular Surfaces Of Four Helix Bundles 1 N N 1 N N A ARG 1 A ARG 2 HELX_P A LEU 30 A LEU 31 1 1 30 B ARG 1 B ARG 2 HELX_P B LEU 30 B LEU 31 1 2 30 FOUR HELIX BUNDLE FOUR HELIX BUNDLE, CAVITY 1UO0 PDB 1 1UO0 GCN4_YEAST UNP 1 P03069 -1 -1 1UO0 -1 -1 1UO0 A 1 1 1 249 281 1UO0 1 33 P03069 A 2 2 34 -1 -1 1UO0 -1 -1 1UO0 B 1 1 1 249 281 1UO0 1 33 P03069 B 2 2 34 1 LEU conflict ILE 5 1UO0 A P03069 UNP 253 6 1 VAL conflict LEU 9 1UO0 A P03069 UNP 257 10 1 LEU conflict ILE 12 1UO0 A P03069 UNP 260 13 1 ASN conflict LEU 16 1UO0 A P03069 UNP 264 17 1 LEU conflict ILE 19 1UO0 A P03069 UNP 267 20 1 VAL conflict LEU 23 1UO0 A P03069 UNP 271 24 1 LEU engineered mutation ALA 26 1UO0 A P03069 UNP 274 27 1 VAL conflict LEU 30 1UO0 A P03069 UNP 278 31 3 LEU conflict ILE 5 1UO0 B P03069 UNP 253 6 3 VAL conflict LEU 9 1UO0 B P03069 UNP 257 10 3 LEU conflict ILE 12 1UO0 B P03069 UNP 260 13 3 ASN conflict LEU 16 1UO0 B P03069 UNP 264 17 3 LEU conflict ILE 19 1UO0 B P03069 UNP 267 20 3 VAL conflict LEU 23 1UO0 B P03069 UNP 271 24 3 LEU engineered mutation ALA 26 1UO0 B P03069 UNP 274 27 3 VAL conflict LEU 30 1UO0 B P03069 UNP 278 31 213 P 41 3 2